The EVGN chart settings shown below allow you to select time intervals of 1 min, 30 mins, an hour or by day - week - month. There is also the ability to change the EVGN chart style to candles, hollow candles, bars, lines or add various indicators. You can even add a symbol and compare history.
The EVGN stock resources shown below were gathered to cut back on time by allowing you to visit multiple sites at once. For your convenience each link clicked will open in a window. In addition to the individual links there is a button at the bottom that will allow you to open all the links at the same time. Note opening all links at once may not work with all browsers. Some browsers block multiple windows, to resolve this please allow that site to use pop-ups.
|View EVGN Detailed Price Forecast - CNN Money||View EVGN Detailed Summary - Google Finance|
|View EVGN Detailed Summary - Yahoo! Finance||View EVGN Stock Research & Analysis - Zacks.com|
|View EVGN Trends & Analysis - Trade-Ideas||View EVGN Major Holders - Barrons|
|View EVGN Call Transcripts - NASDAQ||View EVGN Breaking News & Analysis - Seeking Alpha|
|View EVGN Annual Report - CompanySpotlight.com||View EVGN OTC Short Report - OTCShortReport.com|
|View EVGN Fundamentals - TradeKing||View EVGN SEC Filings - Bar Chart|
|View Historical Prices for EVGN - The WSJ||View Performance/Total Return for EVGN - Morningstar|
|View the Analyst Estimates for EVGN - MarketWatch||View the Earnings History for EVGN - CNBC|
|View the EVGN Earnings - StockMarketWatch||View EVGN Buy or Sell Recommendations - MacroAxis|
|View the EVGN Bullish Patterns - American Bulls||View EVGN Short Pain Metrics - ShortPainBot.com|
|View EVGN Stock Mentions - StockTwits||View EVGN Stock Mentions - PennyStockTweets|
|View EVGN Stock Mentions - Twitter||View EVGN Investment Forum News - Investor Hub|
|View EVGN Stock Mentions - Yahoo! Message Board||View EVGN Stock Mentions - Seeking Alpha|
|View Insider Transactions for EVGN - SECform4.com||View Insider Transactions for EVGN - Insider Cow|
|View EVGN Major Holdings Summary - CNBC||View Insider Disclosure for EVGN - OTC Markets|
|View Insider Transactions for EVGN - Yahoo! Finance||View Institutional Holdings for EVGN - NASDAQ|
|View EVGN Stock Insight & Charts - FinViz.com||View EVGN Investment Charts - StockCharts.com|
|View EVGN Stock Overview & Charts - BarChart||View EVGN User Generated Charts - Trading View|
Biomica Announces Participation in the Microbiome Invest Conference in London May 23, 2018
Posted on Monday May 14, 2018
REHOVOT, Israel, May 14, 2018-- Biomica, a subsidiary of Evogene Ltd., an emerging biopharmaceutical company developing innovative microbiome-based therapeutics utilizing Evogene's Computational Predictive ...
Evogene Financial Results for the First Quarter of 2018 Earnings Announcement Schedule
Posted on Thursday May 10, 2018
REHOVOT, Israel, May 10, 2018-- Evogene Ltd., a leading biotechnology company developing novel products for life science markets, announced today that it will release its financial results for the first ...
Evogene and Marrone Bio Innovations Announce Phase Advancement in their Insect Control Collaboration
Posted on Tuesday May 08, 2018
Evogene Ltd. (EVGN) (EVGN.TA), a leading biotechnology company developing novel products for life science markets, and Marrone Bio Innovations Inc. (MBI), (MBII), a leading global provider of bio-based pest management and plant health products, announced today advancement of genes into Phase I in their insect control collaboration following positive results in model plants. Novel genes isolated from MBI’s microbial assets were discovered as part of Evogene’s Ag-Seeds division collaboration with MBI and showed insecticidal activity against numerous insects from the Lepidoptera and Hemiptera orders in model plants. The Evogene Ag-Seeds division and MBI insect control collaboration was initiated in July 2014 with the mission of bringing to market novel microbe-based insect control solutions viz.
Biomica, Evogene’s Newly Established Subsidiary, Announces Therapeutic Areas of Focus
Posted on Tuesday May 01, 2018
Biomica, a subsidiary of Evogene Ltd. (EVGN) (EVGN.TA), an emerging biopharmaceutical company developing innovative microbiome-based therapeutics utilizing Evogene's Computational Predictive Biology (CPB) platform, announced today its focus on the development of therapies for antibiotic resistant bacteria, Immuno-Oncology and GI related disorders. The human gut microbiome is the collection of trillions of micro-organisms that exist in the digestive tract. The search for microbiome therapies and treatments is a rapidly growing focus for bio-therapeutics research and development, with the potential to reach $9.9Bn annual sales by 20242.